Skip to Content

WPI 2285 (Propafenone hydrochloride extended-release 225 mg)

Pill with imprint WPI 2285 is White, Capsule-shape and has been identified as Propafenone hydrochloride extended-release 225 mg. It is supplied by Actavis Pharma, Inc..

Propafenone is used in the treatment of atrial fibrillation; wolff-parkinson-white syndrome; atrial flutter; ventricular tachycardia and belongs to the drug class group I antiarrhythmics. Risk cannot be ruled out during pregnancy. Propafenone 225 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for WPI 2285

Propafenone hydrochloride extended-release

Imprint:
WPI 2285
Strength:
225 mg
Color:
White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Group I antiarrhythmics
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Actavis Pharma, Inc.
National Drug Code (NDC):
00591-2285

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide